Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-086301
Filing Date
2025-06-13
Accepted
2025-06-13 16:43:00
Documents
1
Period of Report
2025-06-12

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1438
  Complete submission text file 0000950170-25-086301.txt   2934
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Issuer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 860 WASHINGTON STREET, 3RD FLOOR NEW YORK NY 10014
Business Address
Scherer Paul C (Reporting) CIK: 0002072453 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39527 | Film No.: 251047279